In his most recent State of the Union speech, President Joe Biden presented a detailed plan to combat the rising costs of prescription drugs, a major issue that affects millions of people in the U.S. Among the measures that Biden proposes is the limitation of out-of-pocket costs for prescription drugs while simultaneously allowing the federal government the right to negotiate drug pricing. This represents a considerable shift from the regulations that have been in place previously surrounding healthcare. Given my position as the CEO of Xevant, I offer my perspective on these developments.

Leave a Reply

Your email address will not be published. Required fields are marked *